Tina Nuebling
- Immunology top 10%
- Immune Cell Function and Interaction 7
- Immune cells in cancer 2
- T-cell and B-cell Immunology 2
- Hematology top 10%
- Acute Myeloid Leukemia Research 2
- Oncology top 10%
- CAR-T cell therapy research 5
-
- Chronic Lymphocytic Leukemia Research 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Helmut R. SalihLudger Große‐HovestCorina BuecheleTobias RaumAlexander SteinleFrank GrünebachBenjamin Joachim SchmiedelPascal Schneider
- Cited by
- ImmunologyHematologyOncology
- Journals
- Blood (3 papers)The Journal of Immunology (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- GermanyJapanUnited States
In The Last Decade
Tina Nuebling
13 papers receiving 450 citations
Peers
Comparison fields: 5 of 50
- Immunology 270
- Hematology 106
- Oncology 247
- Genetics 37
- Cancer Research 45
Countries citing papers authored by Tina Nuebling
This map shows the geographic impact of Tina Nuebling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Nuebling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Nuebling more than expected).
Fields of papers citing papers by Tina Nuebling
This network shows the impact of papers produced by Tina Nuebling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Nuebling. The network helps show where Tina Nuebling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tina Nuebling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 46 | |
| 2 | 2018 | 14 | |
| 3 | 2016 | 14 | |
| 4 | 2016 | 7 | |
| 5 | Death Receptor Expression on Blasts in AML Is Associated with Unfavorable Prognosis. | 2015 | 8 |
| 6 | 2013 | 86 | |
| 7 | 2013 | 16 | |
| 8 | 2013 | 5 | |
| 9 | 2012 | 49 | |
| 10 | 2012 | 1 | |
| 11 | 2012 | 29 | |
| 12 | 2012 | 179 | |
| 13 | 2012 | 1 |
About Tina Nuebling
Tina Nuebling is a scholar working on Immunology, Hematology and Oncology, having authored 13 papers that have together received 455 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (5 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Immune cells in cancer (2 papers), T-cell and B-cell Immunology (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Immunology (270 citations), Hematology (106 citations) and Oncology (247 citations). Tina Nuebling has collaborated with scholars based in Germany, Japan and United States. Frequent co-authors include Helmut R. Salih, Ludger Große‐Hovest, Corina Buechele, Tobias Raum, Alexander Steinle, Frank Grünebach, Benjamin Joachim Schmiedel, Pascal Schneider, Gundram Jung and Miyuki Azuma. Their work appears in journals such as Blood, The Journal of Immunology, Molecular Cancer Therapeutics, Molecular Therapy and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.